Novavax Soars on $1.2 Billion Sanofi Vaccine Licensing Deal Yahoo FinanceNovavax shares spike 120% on Sanofi deal to commercialize Covid vaccine, develop combination shots CNBCNovavax gets cash infusion with Sanofi licensing deal – Washington Business Journal The Business JournalsNovavax Stock Surges 120% on $1.4 Billion Deal With Sanofi Barron’sNovavax (NVAX) Shares Soar on $1.2 Billion Sanofi Vaccine Licensing Deal Bloomberg